We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Trident Lifeline Ltd informed BSE that its subsidiary, Trident Mediquip Limited (TML), first allotted equity shares to other shareholders via a private placement, which diluted Trident Lifeline's holding in TML to 57.10%. Following this, Trident Lifeline acquired an additional 2.67% equity stake in TML from existing shareholders, raising its holding to 59.77%. TML operates in the pharmaceuticals and chemicals industry, with a turnover of Rs. 21.29 crore in FY25 (Rs. 20.58 crore in FY24, Rs. 28.77 crore in FY23). The transaction is a related party deal (TML being a subsidiary), but has been carried out at arm's length, with certain promoter-group directors having an interest in the acquired entity.
Trident Lifeline has consolidated its majority control in subsidiary TML, reinforcing its position in the pharma/chemicals segment. The dilution from the private placement to other shareholders slightly reduced the holding before the top-up, but net effect is a stronger grip on the subsidiary — a marginally positive signal for long-term consolidation, though the small size and related-party nature of the deal limit its broader stock impact.